<ui-view class="container">
<h3 class="align-center all-news">All News</h3>
<ul class="container news-home">
	<li>
		<p>
			<strong>Apr. 17, 2018</strong> - Glycan Therapeutics has released 12 new compounds under our Azido tag. This release also marks our first publicly available Glc2S compound, <strong>#285!</strong> To check out our new compounds, <a ui-sref="products.compounds({date: '2018-04-13'})">click here.</a>
		</p>
	</li>
	<li>
		<p>
			<strong>Feb 2, 2018</strong> - HAPPY NEW YEAR!!! Glycan Therapeutics is releasing a new online compound builder to help customers build and find the perfect compound to suit their needs. Check out our new online service by <a ui-sref="demo">clicking here</a>.
		</p>
	</li>
	<li>
		<p>
			<strong>Dec. 12, 2017</strong> - Glycan Therapeutics now provides microarray analysis for Heparin Sulfates as part of our evergrowing services. Find out how to utilize our 52 library for your screening needs by <a ui-sref="services.analysis">clicking here.</a>
		</p>
	</li>
	<li>
		<p>
			<strong>Nov. 29, 2017</strong> - The scientists of Glycan Therapeutics have published an article in the latest publication of Chemical Science, the flagship journal of the Royal Society of Chemistry.
		</p>
	</li>
	<li>
		<p>
			<strong>Oct. 30, 2017</strong> - Additional Azido compounds have been released, and in celebration of our new compounds (and the launch of our e-commerce), people who use our e-commerce platform get an additional <strong>25% off</strong> with orders over <strong>$300</strong>. This promotion will run from <strong> Oct. 30, 2017 to Dec. 1, 2017.</strong> To check out the updated Azido library, <a ui-sref="products.compounds({tag: 'Azido'})">click here.</a>
		</p>
	</li>
	<li>
		<p>
			<strong>Sept. 2017</strong> - A new article published in Science Translational Medicine proves the importance of synthetic heparin. <a ui-sref="news.detailed({newsId: '09-2017'})">Read more.</a>
		</p>
	</li>
	<li>
		<p>
			<strong>Mar. 2017</strong> - Glycan Therapeutics has released 14 new compounds under the Biotin tag to its catalog. To check out our new line of compounds, <a ui-sref="products.compounds({tag: 'Biotin'})">click here</a>.
		</p>
	</li>
	<li>
		<p>
			<strong>Sept. 2016</strong> - Glycan Therapeutics has added 32 new compounds to its catalog. Each new compound has an Azido functional group that can be used to couple with a flourescent or affinty tag. These new compounds are only available through <a ui-sref="products.compounds({tag: 'Azido'})">Glycan Therapeutics</a>.
		</p>
	</li>
	<li>
		<p>
			<strong>Oct. 2015</strong> - Glycan Therapeutics has been awarded a SBIR phase II contract from National Institute of Cancer with a total budget of close to $1 million over two years. The contract has commissioned the company to synthesize a library of heparan sulfate oligosaccharides for cancer-related research.
		</p>
	</li>
</ul>
</ui-view>